Engineers Gate Manager LP Enanta Pharmaceuticals Inc Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.18 - $10.78 $228,181 - $300,708	27,895 New	27,895 $262,000
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $210,481 - $405,593	10,178 New	10,178 $217,000
Q3 2020 Nov 16, 2020	SELL	$43.36 - $53.53 $193,385 - $238,743	-4,460 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$46.37 - $57.58 $206,810 - $256,806	4,460 New	4,460 $224,000
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $302,454 - $466,240	-7,520 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$57.95 - $66.61 $73,190 - $84,128	1,263 Added 20.19%	7,520 $465,000
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $193,277 - $283,642	3,217 Added 105.82%	6,257 $376,000
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $247,152 - $295,944	3,040 New	3,040 $256,000

107

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $105M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.